Healthcare >> CEO Interviews >> October 29, 2004
DR STEPHEN LITTLE is Chief Executive Officer: of DxS Ltd. Dr. Little has
over 15 years' experience in the biotechnology industry and was a board
and executive team member during his 11 years at AstraZeneca
Diagnostics. He had overall responsibility for the scientific strategy
of the business. Dr.Little has extensive experience in the development
of nucleic acid based diagnostic products and services for human genetic
analysis. The Diagnostics business was in the forefront of the human
genetics analysis market and DxS benefits from the accumulated
technical, regulatory and commercial know-how gained from many years
experience as an early mover in this sector. Profile
Dr. Little: Well, the Dx in DxS stands for diagnostics and the S is for
services. We are a company that provides genetic analysis service to
